Diabetes Mellitus Clinical Trial
Official title:
Determining the Normal Toe-Brachial Index in Young Adults
The Toe-Brachial Index (TBI) that has been using in our laboratory is 0.6, but the average value we measured in normal individuals is about 1.0, furthermore, we can not find out the reference of TBI that is currently being used. The purpose of this study is to determine the more accurate value of TBI and Ankle-Brachial Index (ABI). In this study, all participants will be required to fill out a demographic questionnaire before the blood pressures test. All participants will have their toe, ankle and brachial systolic blood pressure measurements to obtain the TBI and ABI.
All participants will fill out a demographic questionnaire that includes:
- Race, gender, age
- Height and weight
- Perceived stress level (potentially measured using Cohen's Perceived Stress scale(PSS))
- Activity level, with description hours per week, cardio versus non-cardio, and
intensity (mild, moderate, intense)
- Smoking history, alcohol consumption, caffeine intake, and drug use (recreational,
medicine - over - the - counter and prescription, including birth control pills)
- Hand dominance, and leg dominance
- Past medical history - with emphasis on cardiovascular disease (hypertension, cancer,
coronary heart disease, diabetes mellitus, high cholesterol, coagulopathies, previous
thromboses) as well as renal, adrenal, and thyroid disorders, Raynaud's phenomenon
- Family medical history (cancer, coronary heart disease, diabetes mellitus, high
cholesterol)
Participants with known existing diabetes, coronary artery disease, or a history of vascular
disease will be included in the study; nevertheless, their results may be analyzed in a
separate cohort for comparison against those undiagnosed with the aforementioned condition.
The TBI (Toe - Brachial Index) will be measured by the following procedure.
- The assessment time and room temperature will be recorded
- The participant should lay supine for a minimum of five minutes in a warm and
comfortable room
- Select the appropriate cuff for each upper arm and each large toe and separately placed
them around the arm and large toe.
- The blood pressure measurements will be performed with photo plethysmography (PPS) and
chart recorder. The phototransducer is connected to the PPS, and the digit cuff is
connected to an aneroid sphygmomanometer.
- The toe and ipsilateral arm systolic blood pressures will be measured up to three times
for accuracy.
- The TBI will be calculated by dividing the averaged toe systolic blood pressure, by the
averaged brachial systolic blood pressure.
The ABI (Ankle - Brachial Index) will be measured by the following procedure.
- The blood pressure cuff will be placed proximal to the malleoli and ultrasound gel
cover the skin overlying the dorsalis pedis and posterior tibial arteries in the foot.
- The dorsalis pedis and posterior tibial arteries blood pressure will be measured by
using hand-held Doppler probe.
- The ankle systolic blood pressure will be taken as the higher pressure of the 2
arteries at the ankle.
- The ABI will be calculated by dividing the ankle systolic blood pressure, by the
averaged brachial systolic blood pressure.
The brachial, toe and ankle blood pressures will be measured on the opposite limbs, and the
TBI and ABI will be calculated following the protocol outlined above.
;
Observational Model: Case-Only, Time Perspective: Cross-Sectional
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03743779 -
Mastering Diabetes Pilot Study
|
||
Completed |
NCT03786978 -
Pharmaceutical Care in the Reduction of Readmission Rates in Diabetes Melitus
|
N/A | |
Completed |
NCT01804803 -
DIgital Assisted MONitoring for DiabeteS - I
|
N/A | |
Completed |
NCT05039970 -
A Real-World Study of a Mobile Device-based Serious Health Game on Session Attendance in the National Diabetes Prevention Program
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT04068272 -
Safety of Bosentan in Type II Diabetic Patients
|
Phase 1 | |
Completed |
NCT03243383 -
Readmission Prevention Pilot Trial in Diabetes Patients
|
N/A | |
Completed |
NCT03730480 -
User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS)
|
N/A | |
Recruiting |
NCT02690467 -
Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm.
|
N/A | |
Completed |
NCT02229383 -
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus
|
Phase 3 | |
Completed |
NCT06181721 -
Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes
|
N/A | |
Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
Recruiting |
NCT04489043 -
Exercise, Prediabetes and Diabetes After Renal Transplantation.
|
N/A | |
Withdrawn |
NCT03319784 -
Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients
|
Phase 4 | |
Completed |
NCT03542084 -
Endocrinology Auto-Triggered e-Consults
|
N/A | |
Completed |
NCT02229396 -
Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo
|
Phase 3 | |
Recruiting |
NCT05544266 -
Rare and Atypical Diabetes Network
|
||
Completed |
NCT01892319 -
An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
|
||
Completed |
NCT05031000 -
Blood Glucose Monitoring Systems: Discounter Versus Brand
|
N/A | |
Recruiting |
NCT04039763 -
RT-CGM in Young Adults at Risk of DKA
|
N/A |